ZALTRAP (AFLIBERCEPT) 25 MG/ML

Zaltrap, also known as ziv-aflibercept, which is an FDA-approved anti-cancer medicine given in combination with a chemotherapy regimen called FOLFIRI (foal-feer-ee) to treat colorectal cancer that has spread. FOLFIRI combines the drugs 5-fluorouracil, leucovorin, and irinotecan.

Zaltrap is an option for people who have had their cancer worsen or have become resistant to the initial therapy used to treat their metastatic colorectal cancer (mCRC).

Zaltrap (Aflibercept) suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship Zaltrap (Aflibercept) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Zaltrap (Aflibercept) is manufactured by SANOFI.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Zaltrap (Aflibercept) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

ZALTRAP, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen

Medicine Name: Zaltrap
Generic Name: Ziv-Aflibercept
Approval Date: August 3, 2012
Company Name: SANOFI.